BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28097508)

  • 1. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis.
    Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK
    Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
    Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK
    Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
    Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
    J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
    Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
    Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of polysaccharide-based nanoparticles containing disease-modifying antirheumatic drugs.
    Zhang N; Wardwell PR; Bader RA
    Pharm Res; 2014 Sep; 31(9):2326-34. PubMed ID: 24595497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
    Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
    AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.
    Zhao J; Zhang X; Sun X; Zhao M; Yu C; Lee RJ; Sun F; Zhou Y; Li Y; Teng L
    Eur J Pharm Biopharm; 2018 Sep; 130():39-47. PubMed ID: 29928978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.
    Ait Bachir Z; Huang Y; He M; Huang L; Hou X; Chen R; Gao F
    Int J Nanomedicine; 2018; 13():5657-5671. PubMed ID: 30288039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation.
    Adin SN; Gupta I; Aqil M; Mujeeb M; Najmi AK
    J Drug Target; 2024 Jul; 32(6):707-723. PubMed ID: 38652489
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
    Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
    Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Albumin Coupled, Cholesterol Stabilized, Lipid Nanoemulsion of Methotrexate, and TNF-α Inhibitor for Improved In Vivo Efficacy Against Rheumatoid Arthritis.
    Li XY; Li H; Zhang Y; Gao S; Dong CP; Wu GF
    AAPS PharmSciTech; 2017 Oct; 18(7):2774-2782. PubMed ID: 28361455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
    Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
    Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis.
    Shafiq A; Madni A; Khan S; Sultana H; Sumaira ; Shah H; Khan S; Rehman S; Nawaz M
    Int J Biol Macromol; 2022 Jul; 213():465-477. PubMed ID: 35661673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Factor kappa B (NF-κB) Targeted Self-Assembled Nanoparticles Loaded with Methotrexate for Treatment of Rheumatoid Arthritis.
    Li X; Qu J; Zhang T; He X; Jiang Y; Chen J
    Med Sci Monit; 2019 Nov; 25():8204-8212. PubMed ID: 31674342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis.
    Previtali V; Petrovic K; Peiró Cadahía J; Troelsen NS; Clausen MH
    Bioorg Med Chem; 2020 Jan; 28(2):115247. PubMed ID: 31843461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery.
    Yu A; Shi H; Liu H; Bao Z; Dai M; Lin D; Lin D; Xu X; Li X; Wang Y
    Int J Pharm; 2020 Feb; 575():118943. PubMed ID: 31830575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.